
Personalising cancer care with digital cancer PROMs
An understanding of patient reported outcomes in cancer care is essential to personalising treatment and making a real difference to health outcomes. Cancer PROMs (patient-reported outcomes measures) have classically been captured using paper-based methods, which are often logistically burdensome and expensive. A small pilot study by Vinehealth Digital Ltd (now part of Sciensus), however, illustrates how digital solutions can fundamentally change things: empowering patient engagement while gaining invaluable insight at a fraction of the cost.
Study overview
Sciensus has a rich history of clinical trial services which help pharma, biotechs and NHS move products through to commercialisation. We have strong relationships with more than 50 pharma companies and have worked to develop a sophisticated decentralised clinical trials function that can operate directly with patients in their own homes right across Europe.
The importance of PROMs in cancer care
PROMs are crucial tools that provide insight from a patient’s perspective with regard to symptoms, functional status, and quality of life. Such measures would be very important in guiding patient care, especially in cancer treatment, where symptom burden and emotional wellbeing have dominant impacts on both treatment outcome and patient satisfaction.
Traditionally, cancer PROMs have been collected using paper questionnaires – a method typically resulting in low response rates and high operational costs.
Learn more about our digital solutions that enable streamlined digital PROMs collection to improve patient care and engagement, leading to significant cost savings and better cancer patient reported outcomes.
The challenge with paper-based cancer PROMs
Of course, collecting PROMs on paper is a laborious job, and it doesn’t come cheap either. Their estimation at Cromwell Hospital was that distributing, chasing, and data entry from paper-based PROMs cost them about £63 per patient. Added to this, the response rate from paper questionnaires was only 7%, making meaningful, actionable data hard to collate.

The digital solution: Sciensus Cancer Companion app
The Cancer Companion app was offered to patients for completing their PROMs and symptom tracking electronically. This helped to create a much easier and user-friendly avenue than using paper for data capture. Patients were invited to download the app and participate in the study in which they were asked to complete PRO measures for tracking key symptoms like pain, fatigue, and changes in mood.
Impact of digital cancer PROMs
Digital cancer PROMs collection has several advantages to the traditional methods. These include a higher response rate that ensures comprehensive data, lower costs thus suitable for routine clinical practice. Real-time data provided by a digital cancer PROMs solution may further enable the health providers to pick up any potential issues at an early stage and therefore improve the overall quality of care and outcomes.
Benefits for patients and healthcare providers
For patients:
- Digital cancer PROMs and symptom tracking empowers patients to actively participate in their care.
- Leads to better cancer patient reported outcomes and improved quality of life.
- The ease of use and real-time feedback provided by the Cancer Companion app enhances patient satisfaction and engagement.
For healthcare providers:
- The high completion rates and cost savings make digital cancer PROMs a valuable tool for healthcare providers.
- Captures comprehensive data on patient experiences, clinicians can tailor treatment plans more effectively and respond promptly to any complications.
- Reduces the need for emergency interventions and hospital admissions.
Summary
- Advancing oncology care – The Cromwell Hospital pilot will show how digital PROMs improve cancer care.
- Boosting patient engagement – The Cancer Companion app helps healthcare providers achieve higher response rates, lower costs, and better patient engagement.
- The future of digital health – Emerging digital solutions will play a huge role in improving patient reported outcomes in cancer care and streamlining healthcare delivery, in the future.